Mineralcorticoid-antagonists in chronic kidney disease and Type 2 Diabetes: Key clinical findings from current studies.

30 June 2021 (10:02 - 10:12)
Organised by:
Congress Presentation Part of: Improving cardiovascular and renal outcomes in diabetic kidney disease Chronic Kidney Disease Open Access Heart Failure 2021

ESC 365 is supported by

ESC 365 is supported by